These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10811365)

  • 1. Inducible nitric oxide synthase activity is expressed not only in inflamed but also in normal colonic mucosa in patients with ulcerative colitis: a potential prognostic marker.
    Colón AL; Menchén L; Lizasoain I; Leza JC; Menchén P; González-Lara V; Moro MA; Lorenzo P
    Am J Gastroenterol; 2000 May; 95(5):1371-3. PubMed ID: 10811365
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis.
    Menchén L; Colón AL; Madrigal JL; Beltrán L; Botella S; Lizasoain I; Leza JC; Moro MA; Menchén P; Cos E; Lorenzo P
    Am J Gastroenterol; 2004 Sep; 99(9):1756-64. PubMed ID: 15330915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of inducible nitric oxide synthase in ulcerative colitis.
    Ikeda I; Kasajima T; Ishiyama S; Shimojo T; Takeo Y; Nishikawa T; Kameoka S; Hiroe M; Mitsunaga A
    Am J Gastroenterol; 1997 Aug; 92(8):1339-41. PubMed ID: 9260802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inducible nitric oxide synthase (iNOS) mRNA in inflamed esophageal and colonic mucosa in a pediatric population.
    Gupta SK; Fitzgerald JF; Chong SK; Croffie JM; Garcia JG
    Am J Gastroenterol; 1998 May; 93(5):795-8. PubMed ID: 9625130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in distribution of three isoforms of nitric oxide synthase in ulcerative colitis.
    Vento P; Kiviluoto T; Järvinen HJ; Soinila S
    Scand J Gastroenterol; 2001 Feb; 36(2):180-9. PubMed ID: 11252411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct determination of colonic nitric oxide level--a sensitive marker of disease activity in ulcerative colitis.
    Rachmilewitz D; Eliakim R; Ackerman Z; Karmeli F
    Am J Gastroenterol; 1998 Mar; 93(3):409-12. PubMed ID: 9517649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.
    Kimura H; Hokari R; Miura S; Shigematsu T; Hirokawa M; Akiba Y; Kurose I; Higuchi H; Fujimori H; Tsuzuki Y; Serizawa H; Ishii H
    Gut; 1998 Feb; 42(2):180-7. PubMed ID: 9536941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
    Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines.
    Kolios G; Rooney N; Murphy CT; Robertson DA; Westwick J
    Gut; 1998 Jul; 43(1):56-63. PubMed ID: 9771406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic infiltration and expression of inducible nitric oxide synthase in human duodenal and colonic mucosa is a characteristic feature of ankylosing spondylitis.
    Lamarque D; Nhieu JT; Breban M; Bernardeau C; Martin-Garcia N; Szepes Z; Delchier JC; Whittle B; Claudepierre P
    J Rheumatol; 2003 Nov; 30(11):2428-36. PubMed ID: 14677189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
    Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin inhibits cytokine-induced nitric oxide production in human colonic epithelium.
    Kolios G; Manousou P; Bourikas L; Notas G; Tsagarakis N; Mouzas I; Kouroumalis E
    Eur J Clin Invest; 2006 Oct; 36(10):720-9. PubMed ID: 16968468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon.
    Roberts PJ; Riley GP; Morgan K; Miller R; Hunter JO; Middleton SJ
    J Clin Pathol; 2001 Apr; 54(4):293-7. PubMed ID: 11304846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn's disease.
    Guihot G; Guimbaud R; Bertrand V; Narcy-Lambare B; Couturier D; Duée PH; Chaussade S; Blachier F
    Amino Acids; 2000; 18(3):229-37. PubMed ID: 10901620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
    Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
    Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment.
    Leonard N; Bishop AE; Polak JM; Talbot IC
    J Clin Pathol; 1998 Oct; 51(10):750-3. PubMed ID: 10023337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of corticosteroids on nitric oxide production in inflammatory bowel disease: are leukocytes the site of action?
    Linehan JD; Kolios G; Valatas V; Robertson DA; Westwick J
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G261-7. PubMed ID: 15374815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of inhibitors of inducible nitric oxide synthase on chronic colitis in the rhesus monkey.
    Ribbons KA; Currie MG; Connor JR; Manning PT; Allen PC; Didier P; Ratterree MS; Clark DA; Miller MJ
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1008-15. PubMed ID: 9023318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C activity of colonic mucosa in ulcerative colitis.
    Sakanoue Y; Hatada T; Horai T; Shoji Y; Kusunoki M; Utsunomiya J
    Scand J Gastroenterol; 1992 Apr; 27(4):275-80. PubMed ID: 1589704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.